Michael Shetzline Net Worth & Insider Trades
Michael Shetzline - CMOSVP,Head-Res&Drug, Ironwood Pharmaceuticals Inc
What is Michael Shetzline's Net Worth?
The current estimated net worth of Ironwood Pharmaceuticals Inc's CMOSVP,Head-Res&Drug, Michael Shetzline, is estimated to be about $2.01M . Michael Shetzline owns about 321,131 units of Ironwood Pharmaceuticals Inc common stock. In the last 3 years at Ironwood Pharmaceuticals Inc, Michael Shetzline has sold an estimated value of $860.7K worth.
What is Michael Shetzline's Past Insider Trading?
Michael Shetzline's largest sale order was 19,322 units , worth over $219.48K on March 1, 2023. In total, Michael Shetzline has made about 14 transactions over 3 years of their time at Ironwood Pharmaceuticals Inc. Michael Shetzline usually trades in March, with the busiest year in 2021. The most recent transaction was a sale order of 10,324 units , worth over $104.48K on May 24, 2023.
Michael Shetzline
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was Michael Shetzline's Salary in 2020?
As CMOSVP,Head-Res&Drug of Ironwood Pharmaceuticals Inc, Michael Shetzline has a total base salary of $464,681 . Michael Shetzline received compensation valued at about $1,891,310 in 2020 after becoming CMOSVP,Head-Res&Drug. The vast majority of their compensation came in the form of a bonus of $100,000 , stock awards of $1,121,001 , other earnings, plans or compensations of $194,558 , and other compensation of $11,040 .
What is Michael Shetzline's' Mailing Address?
- Mailing address is 100 Summer Street, Suite 2300 Boston MA 02110 MA
Ironwood Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Mark Mallon* | 2020 | $801,173 | - | $5,423,731 | - | $585,169 | $11,040 | $6,821,113 |
Mark Mallon* | 2019 | $750,000 | $880,000 | $3,692,810 | $3,804,331 | $797,063 | $144,596 | $10,068,800 |
Mark Mallon* | 2018 | - | - | - | - | - | - | - |
Gina Consylman | 2020 | $512,751 | - | $1,676,402 | - | $264,652 | $11,040 | $2,464,845 |
Gina Consylman | 2019 | $480,000 | $250,000 | $1,467,731 | $888,546 | $358,800 | $8,502 | $3,453,579 |
Gina Consylman | 2018 | $415,000 | - | $782,385 | $501,764 | $207,500 | $8,040 | $1,914,688 |
Thomas McCourt* | 2020 | $576,120 | - | $2,465,327 | - | $357,409 | $11,040 | $3,409,896 |
Thomas McCourt* | 2019 | $511,250 | - | $1,760,143 | $2,370,159 | $454,272 | $8,502 | $5,104,327 |
Thomas McCourt* | 2018 | $465,000 | - | $549,641 | $869,479 | $232,500 | $34,002 | $2,150,622 |
Jason Rickard | 2020 | $473,314 | - | $1,479,191 | - | $258,338 | $11,040 | $2,221,883 |
Jason Rickard | 2019 | - | - | - | - | - | - | - |
Jason Rickard | 2018 | - | - | - | - | - | - | - |
Michael Shetzline, M.D., Ph.D. | 2020 | $464,681 | $100,000 | $1,121,001 | - | $194,558 | $11,040 | $1,891,310 |
Michael Shetzline, M.D., Ph.D. | 2019 | - | - | - | - | - | - | - |
Michael Shetzline, M.D., Ph.D. | 2018 | - | - | - | - | - | - | - |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1446847/000104746921001006/a2243150zdef14a.htm
What are Ironwood Pharmaceuticals Inc's Past Insider Trades?
Ironwood Pharmaceuticals Inc's most recent insider trade came on June 1, 2023 by Thomas McCourt who sold 26,632 units worth $284.96K . In the last 13 years, insiders at Ironwood Pharmaceuticals Inc have sold an estimated value of $119.28M and bought an estimated value of $42.1M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are Mark Currie, Director, Thomas McCourt, Chief Executive Officer, and Bryan E Roberts, Director .
IRONWOOD PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |